| Model Number |
995MS29 |
| Medical Device Problem Codes |
Patient Device Interaction Problem (4001); Intravalvular regurgitation (4068)
|
| Health Effect - Clinical Codes |
Thrombosis/Thrombus (4440); Aortic Valve Insufficiency/ Regurgitation (4450)
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported that a patient implanted with a freestyle valve is being evaluated for a transcatheter valve-in-valve replacement.It was noted that there was possible plaque/thrombus observed in the ascending aorta. no specific symptoms or additional adverse outcomes were reported, and the device remains in service.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated b1 updated b2 updated b5 updated h6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received additional information which stated that subsequently, 5 days later, a transcatheter valve of a different manufac turer was implanted valve-in-valve.The reason for intervention was reported as mild to moderate aortic regurgitation (ar).No additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated e.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|